Clinuvel Pharmaceuticals Limited (CLVLF.PK) released earnings for first half that Dropped, from last year
The company's bottom line came in at A$10.442 million, or A$0.2063 per share. This compares with A$14.075 million, or A$0.28 per share, last year.
The company's revenue for the period rose 3.6% to A$36.930 million from A$35.645 million last year.
Clinuvel Pharmaceuticals Limited earnings at a glance (GAAP) :
-Earnings: A$10.442 Mln. vs. A$14.075 Mln. last year.-EPS: A$0.2063 vs. A$0.28 last year.-Revenue: A$36.930 Mln vs. A$35.645 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.